Bills: SB6, SB7, SB8, SB11, SB12, SB13, SB15, SB 6, SB 7, SB 8, SB 11, SB 12, SB 13, SB 15, SB 17

Keywords: SB 6, Woman and Child Protection Act, abortion, abortion-inducing drugs, medication abortion, mifepristone, misoprostol, pro-life, pro-choice, Texas abortion law, civil liability, qui tam, private enforcement, bounty hunter law, attorney general, parens patriae, abortion litigation, anti-SLAPP, Texas Citizens Participation Act, fee shifting

Transcript Highlights:

• </c> pharmaceuticals for use by optometrists. pharmaceuticals for use by optometrists.
• </c><01:43:50.880><c> agents</c> certified to use pharmaceutical agents certified to use pharmaceutical
• </c> that expand the list of pharmaceutical that expand the list of pharmaceutical agents agents agents
• That there is some oversight in that compounding catchall in Roman I.
• </c><01:55:57.920><c> catchall</c> oversight in that compounding catchall oversight in that compounding

Keywords: 1191, senate, all

Transcript Highlights:

• It's what the pharmaceutical industry negotiates their prices on.
• I represent the Pharmaceutical Care Management Association, the nation's trade association for the PBM
• We asked pharmaceutical manufacturers.
• We asked pharmaceutical manufacturers.
• These are not compounded drugs. These are not, like, those sorts of things.

Bills: HB591, HB765, HB826, HB870, HB938, HB1151, HB1162, HB1176, HB1196, HB1236, HB1241

Keywords: family leave, insurance, paid leave, employment benefits, caregiver support, liability insurance, coverage defenses, direct action, judgment enforcement, legal procedures, insurance referrals, compensation, non-licensed agents, consumer protection, insurance products, HB 870, Act 907, Louisiana insurance, health insurance, prescription drugs

Transcript Highlights:

• It prohibits pharmaceutical manufacturers from unilaterally restricting where 340B-priced medications
• That represents a 20% year-over-year increase, and this program and its discounts with pharmaceutical
• I ask you to put the health of rural communities over the profits of big pharmaceutical companies and
• In closing, I urge you not to view a vote against this bill as a vote for pharmaceutical companies.
• Ann Murray with Bristol-Myers Squibb, a research-based pharmaceutical company committed to delivering

Bills: SB5904, SB5915, SB6025, SB5933, SB5990, SB5981

Keywords: nursing titles, licensure, healthcare professionals, patient safety, professional standards, SB 5915, health technology assessment, HTA, clinical committee, medical technology review, coverage determination, state-purchased health care, Washington health care, RCW, evidence-based medicine, cost-effectiveness, safety and efficacy, Medicare coverage, national coverage determination, clinical guidelines

Transcript Highlights:

• Which seeks to establish parity between traditional and compounding pharmacies pharmacies by implementing
• pharmaceutical company, who would be liable?
• Depending on the circumstances, at the very minimum, the pharmaceutical company should be liable for
• These pharmaceutical companies were giving immunity. So what is a family to do?
• The program is intended to indemnify pharmaceutical companies from liability so they can actually produce

Bills: HB 3772, HB 1656, HB 4504, HB 1896, HB 4420, HB 4421, HB 4076, HB 3708, HB 2806, HB 3540, HB 1586, HB 5459, HB 4553, HB 4535, HB 3811, HB 3749, HB 4255, HB 4051, HB 5098, HB 3554, HB 4539, HB 5274

Keywords: e-cigarettes, health and safety, regulations, directory, penalties, regulation, certification, compliance, manufacturers, FDA, nicotine, mental health, emergency detention, paramedic authority, mental illness, healthcare facility, public health, covenants not to compete, health care practitioners, physicians

Transcript Highlights:

• You know, so for a pharmaceutical, for a potential therapeutic, let's say.
• But with a lot of pharmaceutical companies, that is not the magic moneymaker.
• And, again, not being greedy, but I think that when we look at the margins. of pharmaceutical drugs or
• Any other pharmaceutical substance is prescribed based on weight, size, and other individual factors.
• Silica fluoride and hydrofluorosilicic acid are compounds used in water fluoridation.

Bills: SB623, SB1266, SB1310, SB1373, SB1580, SB1952, SB2032, SB2269, SB2544, SB2653, SB2796

Keywords: pharmacist, vaccine administration, COVID-19, exclusive authority, healthcare, Medicaid, provider enrollment, credentialing, administrative burden, Texas Health and Human Services, senior retirement communities, emergency response, residential safety, contract provisions, health and safety regulations, medical staff privileges, hospital administration, healthcare regulation, Texas Health and Safety Code, consistency in privileges

Transcript Highlights:

• Sure, so you may have heard about a bankruptcy of the various pharmaceutical companies involved in the
• I'm sorry, so there was an opioid settlement where we were holding the pharmaceutical companies accountable
• Pharmaceutical companies.
• Is it because pharmaceuticals are going up? Can you just explain a little bit more? Sure.
• of salaries and benefits, the same positions do cost more each year, so the reduction may further compound

Keywords: 988, house, all

Transcript Highlights:

• Yes, one is a natural product, and one is a pharmaceutical.
• I myself have tried a variety of pharmaceuticals in hopes of improving my conditions, but to no avail
• I was addicted to fentanyl, heroin, and pharmaceuticals.
• How can you leave the differences... differentiation, assessment, and evaluation of which compounds to
• Pharmacokinetics, the chemistry, the mechanisms of action, the indications of all these compounds, of

Bills: SB31, SB33, SB510, SB871, SB1868, SB2024, SB2166, SB2309, SB2880, SJR27, SJR39, SJR40, SB 31, SB 33

Keywords: SB 31, Life of the Mother Act, Texas abortion law, medical emergency, reasonable medical judgment, pregnancy complications, maternal health, life-threatening condition, ectopic pregnancy, spontaneous abortion, miscarriage, unborn child, abortion exception, abortion ban, physician liability, health care liability claim, aiding and abetting, Texas Medical Board, State Bar of Texas, continuing medical education

Transcript Highlights:

• It's a fast-acting medication that uses a compound that's already produced within the human body.
• Accordingly, to ensure that residents of Massachusetts continue to have access to compounded medications
• Thus, Section 503 of the federal law works to prohibit 503Bs from selling compounded drug products to
• a traditional wholesaler such as Cencora or McKesson, who then resells the compounded drug to another
• Nevertheless, we do not want another compounding disaster to occur in light of the New England Compounding

Keywords: 995, all

Summary: The Joint Committee on Public Health held a hearing focused on children’s health, disease prevention, screening, treatment, and pharmacy-related bills. The chair explained that the session was for public testimony only, with no votes or decisions taken that day, and outlined the three-minute limit for individual testimony. The committee then heard testimony on a range of bills, including H. 2413 on adding electromagnetic sensitivity to the state’s MAVEN registry, S. 1508 and H. 2433 on creating an amputation prevention task force, H. 2535 and S. 1551 on establishing a naloxone purchase trust fund, S. 1635 on authorizing pharmacists to provide opioid use disorder treatment, H. 2385 on creating a special commission on avian influenza, and S. 1497 on patient safety and non-FDA-approved compounded drugs. Testimony on H. 2413 came largely from advocates and individuals who described electromagnetic sensitivity as a real health condition and argued that adding it to the registry would improve data collection, provider education, and public awareness. Testimony on the amputation prevention task force bills came from the American Diabetes Association and podiatry groups, who said diabetes-related amputations are often preventable, disproportionately affect people of color, and could be reduced through earlier screening, better care coordination, and improved insurance coverage for preventive foot care. On the naloxone trust fund bills, a representative, emergency physician, and nurse testified that hospitals often cannot reliably send overdose patients home with naloxone because of billing and reimbursement barriers, and that a bulk-purchase fund would expand access at no added cost to payers or providers. The committee also heard strong support for S. 1635 from pharmacists and public health researchers, who said community pharmacists could safely initiate and maintain buprenorphine treatment and help close gaps in opioid use disorder care. On H. 2385, a local board of health chair supported a special commission on avian influenza, citing gaps in emergency preparedness and the need for clearer coordination across agencies. On S. 1497, a pharmacy representative opposed restrictions on compounded drugs from outsourcing facilities, warning that changes could reduce access to life-saving medications and harm patient safety. No votes or formal actions were taken during the hearing.

Transcript Highlights:

• So the insurance companies do not see the bill for the pharmaceuticals.
• So the insurance companies do not see the bill for the pharmaceuticals.
• So the insurance companies do not see the bill for the pharmaceuticals.
• So the insurance companies do not see the bill for the pharmaceuticals.
• So the insurance companies do not see the bill for the pharmaceuticals.

Keywords: 1191, senate, all

Transcript Highlights:

• We are proud to serve tens of thousands of Arizona consumers who rely on kratom for non-pharmaceutical
• Child safety caps, the things normal pharmaceuticals require anyway.
• Child safety caps, the things normal pharmaceuticals require anyway.
• Normal pharmaceuticals require that anyway, so if that answers your question. Thank you.
• We can't tell the difference, as a synthetic compound would look exactly like a natural compound on our

Summary: The committee approved the minutes and then heard a long series of bills, mostly from Senators Hoffman, Fernandez, and Bolick. Early action included SB 1436 on school bond/override ballot language, which passed 4-3 after brief debate over ballot length and transparency. SB 1568, requiring election systems to keep clocks within 60 seconds of official time and making violations a misdemeanor, was amended and passed 4-3 despite concerns about machine failures and the breadth of the penalty. SB 1569, limiting special election board members from collecting voter registrations while assisting confined voters, also passed 4-3 after testimony from county officials and a deputy registrar describing alleged misuse of SEBs. SB 1746, requiring schools to serve as polling places and closing schools on regular primary/general election days for staff training, passed 4-3 over objections about school autonomy and safety. SB 1295, allowing certain incarcerated people needing long-term care or treatment to be transferred to contracted medical institutions, passed unanimously after an amendment narrowing the medical eligibility language. The committee then took up SB 1067, a county blight/abatement bill allowing property tax bills to include assessments for removing rubbish, debris, and dilapidated structures; county officials from Gila and Pima Counties strongly supported it, and it passed 7-0. SB 1285, which would have repealed kratom protections and added kratom and its alkaloids to the narcotic-drug list, drew strong opposition from industry and a pharmacist and failed 3-4 after debate over safety, regulation, and criminal penalties. SB 1413, removing the $100,000 restitution cap for serious injury or death caused by a moving violation, passed after a short explanation that it was intended to conform statutes to a prior Arizona Supreme Court ruling. SB 1476, making prenatal exposure to dangerous or narcotic drugs and fetal alcohol syndrome a class six felony child neglect offense with an affirmative defense for mothers who completed treatment, drew emotional testimony from a foster/adoptive parent and opposition from reproductive justice and criminal defense advocates; it passed 4-2. Later, SB 1585, creating standards and funding mechanisms for sex offender-specific evaluations, treatment, and polygraphs, passed 4-2 after supporters argued it would improve oversight and opponents questioned the added surcharge and appropriation. SB 1662, requiring probation conditions to be the least restrictive necessary and tailored to risk and needs, passed 5-0 with support from justice reform advocates and defense attorneys. SB 1664, adjusting constable nomination signature requirements in Maricopa and Pima Counties, passed unanimously after county association support. The committee then began SB 1666 on in-state custodial interference, with the sponsor and a supporter describing repeated violations of custody orders and arguing for a tiered civil-penalty-to-felony structure; the transcript ends during questioning on that bill.

Transcript Highlights:

• Pharmaceutical companies that make money when an opiate is prescribed instead of CBD recommended.
• CBD, even though many non-intoxicating hemp compounds are used safely and legally across the country.
• Instead, the bill is overly aggressive, criminalizing legal hemp compounds and placing unnecessary burdens
• The challenges they face in recovery are compounded by the limitations imposed by certain pieces of legislation

Bills: SB5, SB11, SB12, SB5, SB11, SB12

Keywords: hemp regulation, consumable products, cannabinoids, occupational licenses, criminal offenses, SB 11, Texas attorney general, election crimes, election law enforcement, criminal prosecution, Election Code, Government Code Chapter 402, local prosecutors, county attorney, district attorney, grand jury, probable cause reports, state election offenses, voter fraud, election integrity

Transcript Highlights:

• the product is a compounded drug that is not FDA approved.
• Most compounders just test for the active ingredient.
• Compounding is, by definition, individualized.
• And one of the points I want to make to everyone is while compounding, we believe in compounding, but
• It doesn't compound anyway.

Summary: The Assembly Business and Professions Committee heard a long agenda of bills, with several cannabis-related measures drawing the most testimony. AB 1598 would extend and standardize licensing timelines for behavioral health professionals, AB 1850 would clarify that real estate wholesalers are subject to licensure and disclosure rules, AB 1794 would allow enteral formula to be shipped directly to patients’ homes, and AB 2402 would update an old cap on fees for multi-service health club studios. The committee also heard AB 1990 on compounded GLP-1 drugs, AB 2249 on cannabis packaging attractive to children, AB 2532 on cannabis beverage serving sizes, AB 2537 on prioritizing cannabis enforcement, and AB 1826 on due process protections for cannabis businesses facing embargoes or recalls. Testimony was generally split between public health or consumer-protection advocates and industry representatives. Supporters of the cannabis bills argued for clearer rules, better consumer safety, and more predictable enforcement, while opponents warned that some proposals could overreach, burden compliant businesses, or restrict legitimate branding and access. On AB 1990, supporters said compounded GLP-1 products need stronger testing and truthful advertising, while pharmacists and compounding advocates said existing law already covers much of the conduct and that the bill could create access problems. On AB 2249 and AB 2532, public health witnesses emphasized risks to children and accidental overconsumption, while industry groups sought narrower language and more implementation time. The committee took several roll-call votes after quorum was established. AB 2249, AB 1826, AB 2402, AB 1794, and AB 2532 were all approved and sent to Appropriations, and AB 1826 was sent to Judiciary. The chair and members repeatedly noted accepted committee amendments and, in several cases, said they were prepared to support the bills with those amendments. Some measures were left open or held pending further action as the hearing continued.

Transcript Highlights:

• We urge caution before advancing any mandates that could compound the affordability crisis already underway
• many health care providers can purchase it through their own vendor agreements with their own pharmaceutical
• relationships with every health care insurance company in the United States, 18 of the top 20 pharmaceutical
• companies, and in 2023, they partnered with TransUnion to enable pharmaceutical advertisers to target
• companies, and in 2023, they partnered with TransUnion to enable pharmaceutical advertisers to target

Bills: HB1496, HB2182, HB2196, HB2242

Keywords: patients' rights, healthcare information, medical confidentiality, health data security, healthcare access, abortion, medications, reproductive health, access, healthcare, PANDA, PANS, treatment access, mental health, legislation, preventive services, state authority, definitions clarification, public health, 904

Transcript Highlights:

• THC was my gateway to pharmaceutical medicines.
• This is about the pharmaceutical lobby. This is about the alcohol lobby.
• Money is made on their products, on pharmaceutical products, to help them just get through a day and
• So, it's not just keeping people off pharmaceuticals by using these products; it's putting them on pharmaceuticals
• So THC-A is a different compound than THC-T. It's a precursor.

Bills: SB5, SB11, SB12, SB 5, SB 11, SB 12

Keywords: hemp regulation, consumable products, cannabinoids, occupational licenses, criminal offenses, SB 11, Texas attorney general, election crimes, election law enforcement, criminal prosecution, Election Code, Government Code Chapter 402, local prosecutors, county attorney, district attorney, grand jury, probable cause reports, state election offenses, voter fraud, election integrity

Transcript Highlights:

• Medical, surgical, dental, chiropractic, hospital, optometric, podiatric, pharmaceutical, ambulance,
• It protects older adults from compounding financial harm, supports economic security, and their ability
• Importantly, that judgment has been compounding interest at Washington's judgment interest rate of 9%
• Simple interest does not grow exponentially the way compounded interest does.
• That 9% seems pretty good when you're comparing it to a 32% APR compounding interest rate if you don't

Summary: The committee held public hearings on several bills. SB 5720 would enact the Uniform Consumer Debt Default Judgments Act, adding complaint and notice requirements before default judgments in consumer debt cases and preserving existing debt-buyer protections; the sponsor and witnesses from consumer and collection groups described it as a compromise measure, and there was broad support with 53 people signed in pro. SB 5833 would allow a vehicle to remain running for up to 30 minutes to keep a pet safe from heat or cold; the sponsor said he would amend liability language, while animal control and police groups raised concerns about shifting the focus away from animal welfare and creating liability issues, though many sign-ins were pro (107 pro, 4 con). SB 5936 would update human trafficking law by allowing prosecution of business entities that knowingly benefit from trafficking, adding confidentiality protections for victims, and creating a process for T and U visa certifications; survivors and advocacy groups supported it, while hospitality and law enforcement groups asked for clarifying amendments, especially on business liability and duplicative visa procedures, and sign-ins showed 24 pro and 283 con. SB 5993 would prohibit interest on new and unpaid medical debt and shorten enforcement of judgments involving medical debt to six years without renewal; supporters said it would reduce financial harm and help patients, while hospitals, physicians, collectors, and business groups warned it could discourage payment and worsen provider finances, especially for rural hospitals, with 129 sign-ins pro and no con sign-ins. Finally, SB 5735 would create state standards for labeling imitation firearms, including BB guns and toy guns, with advisories and penalties for altered markings; the sponsor said it was intended to reduce mistaken shootings, while gun-rights and firearms-training witnesses argued federal law already covers the issue and that the bill would burden lawful training and competition, with 8 pro and 184 con sign-ins. The committee closed each public hearing and adjourned without recorded votes on the bills.

Transcript Highlights:

• And we recognized that quite a while back and took action, where we now have the pharmaceutical companies

Bills: HB136, HB451, SB425, SB466, SB905, SB1986, SB2311, SB2450, SB2805, SB2826, SB2919, SB3001

Keywords: Medicaid, lactation, healthcare, consultation, reimbursement, maternal health, infant care, commercial sexual exploitation, child sex trafficking, human trafficking, child welfare, foster care, DFPS, Department of Family and Protective Services, juvenile probation, risk assessment, needs assessment, trauma screening, child abuse prevention, exploitation screening

Summary: The committee met with a quorum and announced it would vote on pending bills at 10:30, with public testimony limited to two minutes. It first took up Senate Bill 905, a TDLR cleanup bill on licensing regulation of speech-language pathologists and audiologists. Senator Zafferini said the committee substitute would streamline advisory board consultation, remove obsolete provisional licenses, and allow any licensed physician to authorize hearing instruments for minors; the substitute was adopted and the bill left pending. The committee then heard House Bill 451, which would require universal screening for commercial sexual exploitation risk for children in DFPS conservatorship and youth under TJJD jurisdiction. The author and witnesses from Children at Risk, the Fort Bend Anti-Trafficking Collective, and Texas CASA supported the bill as a prevention tool with existing infrastructure and training; the committee adopted the substitute and left the bill pending. The committee next considered Senate Bill 466, which would clarify that families may request a fetal death certificate at any gestational age, while keeping existing filing requirements for physicians. A constituent father testified about losing his 11-week-old daughter and being told he could not obtain a certificate, which he said prevented funeral arrangements; the substitute was adopted and the bill left pending. Senate Bill 2311 followed, requiring residential treatment centers to have a written agreement with the school that will educate resident children before becoming operational. The author cited a local dispute where an RTC and school district lacked communication, and witnesses from Texas CASA and Disability Rights Texas supported clearer educational planning while suggesting the Education Code may need conforming changes; the bill was left pending. The committee then heard Senate Bill 2826, known as Alyssa’s Law, which would create a statewide education program on medical child abuse for medical students, health care professionals, and CPS caseworkers. The author and Sheriff Bill Weyburn described Alyssa’s case as involving repeated unnecessary surgeries and argued the bill would improve awareness and early identification, while several witnesses and members raised concerns about false accusations, impacts on medically fragile children, and the need for scientific, peer-reviewed training and safeguards. After extensive discussion, the chair left the bill pending. The committee also heard House Bill 136, which would add certified lactation consultants as Medicaid providers to expand breastfeeding support; witnesses from lactation and nutrition fields said the bill would improve access, maternal and infant health, and long-term savings, and the bill was left pending. Finally, the committee took up Senate Bill 2805, a surprise-billing/arbitration measure that would clarify provider identifiers and shift arbitration costs to the losing party. The author said the substitute was a legislative counsel draft with no substantive difference, and witnesses from the Texas Medical Association, Texas Society of Anesthesiologists, and U.S. Anesthesia Partners supported the bill as a modest improvement that would reduce administrative confusion and make arbitration fairer without weakening patient protections. Members discussed how arbitration costs affect settlement behavior and how to define the “winner” in close cases. The bill was heard but not voted out during this segment.

Transcript Highlights:

• I would ask the pharmaceutical company, and I'd have them at my door the next day.
• something sinister happened during the COVID-19 pandemic, where the federal government and the pharmaceutical
• This is where the big pharmaceutical companies—I'm sorry, the big insurance companies—are making all

Bills: SB331, SB883, SB926, SB1137, SB1138, SB1144, SB1151, SB1236, SB1270, SB1522, SB1869, SB2207, SB2422

Keywords: healthcare, cost disclosure, transparency, administrative penalties, health facility compliance, COVID-19, off-label use, prescription drugs, patient access, medical standards, insurance, physician ranking, incentives, fiduciary duty, health plan issuers, SB 1137, group home, assisted living, residential care, board and care

Summary: The committee heard testimony on Senate Bill 883, which would protect physicians’ ability to prescribe off-label medications and treatments, framed by the author as a “Right to Treat” measure tied to COVID-19 care. Supporters, including physicians and patient-choice advocates, said the bill would safeguard the doctor-patient relationship and prevent interference by boards, pharmacies, or hospitals. Several witnesses described using hydroxychloroquine, ivermectin, budesonide, antibiotics, steroids, and monoclonal antibodies during the pandemic, and said they faced complaints, board scrutiny, or pharmacy refusals for those prescriptions. The bill was left pending after public testimony closed. The committee then took up Senate Bill 331, which would extend hospital price-transparency requirements to additional health care facilities such as freestanding ERs, urgent care and retail clinics, ambulatory surgical centers, outpatient clinics, and birthing centers. Proponents argued that broader disclosure of prices for shoppable services would help consumers compare costs and reduce surprise billing, while opponents from ambulatory surgery centers said the bill would impose costly compliance burdens on small providers and that insurers or the state already have much of the needed data. The bill was also left pending. Senate Bill 2422 would expunge Texas Medical Board records and impose reparations for disciplinary actions tied to COVID-era treatment decisions, including references to ivermectin, hydroxychloroquine, budesonide, and masks. The author and supporters argued that doctors were unfairly targeted for trying to save patients and should be made whole; the Texas Medical Board representative said most pandemic complaints were dismissed, that actions generally involved broader issues such as privileges, documentation, or informed consent, and that no physician was disciplined solely for prescribing off-label COVID medications. The bill was left pending. Finally, the committee heard Senate Bill 2207, which would loosen Texas Medical Board rules on physicians advertising themselves as board certified, especially by reducing barriers tied to maintenance of certification requirements. Supporters said the current rule is overly restrictive, inconsistent, and costly, and that it drives physicians out of practice; they also said Texas is one of only a few states with such a rule. Witnesses described hospitals using the rule against physicians and said the change would improve transparency and competition. The bill remained pending after testimony.

Transcript Highlights:

• Fred Nott, representing the Pharmaceutical Research and Manufacturers of America, in support.
• Fred Nott, we're representing the pharmaceutical research and manufacturers of America in support.
• Alison Ramey, here today on behalf of the Pharmaceutical Care Management Association, in opposition to
• I mean, clearly there are issues to deal with in the pharmaceutical industry, and this legislature has
• called. the challenges with PBMs and how it's increasing the cost of pharmaceutical access to patients

Summary: The committee heard several health-related measures. SB 27 by Senator Umberg would revise and expand California’s CARE Court by limiting the expansion to people with bipolar I disorder with psychotic features, clarifying the definition of “clinically stabilized,” and narrowing the role of nurse practitioners and physician assistants. Supporters, including behavioral health officials and family members, said the bill would reduce dismissals and better serve people with severe illness; opponents warned the expansion would strain county staffing and housing resources and could undermine voluntary engagement. The bill passed on a do pass motion to the Committee on Public Safety. SB 503 by Senator Weber Pierson would require AI tools used in health care facilities to be identified, monitored, and mitigated for bias when used in clinical decision-making or resource allocation. The author and supporters from Kaiser Permanente and the California Medical Association said the bill would help prevent discriminatory outcomes and improve trust and safety. The committee discussed the need to clarify developer and deployer responsibilities, and the bill passed as amended to Privacy and Consumer Protection. SB 68 by Senator Menjivar would require restaurants to provide written allergen information for the top nine food allergens, with tiered flexibility for smaller establishments. The bill was supported by patients, families, nurses, and allergy organizations, who described severe reactions and the difficulty of relying on verbal disclosures alone. The California Restaurant Association opposed unless amended, seeking broader use of the national model food code and additional liability language. The bill passed as amended to Appropriations. The committee also heard SB 403 by Senator Blakespear, which would remove the sunset from the End of Life Option Act; supporters described the law as a compassionate, well-functioning option for terminally ill patients, while faith-based groups opposed it. The bill passed to Judiciary. Later, SB 41 by Senator Wiener was introduced to rein in pharmacy benefit manager practices that steer patients to mail-order pharmacies and reimburse community pharmacies below cost; community pharmacists and several health organizations testified in support, describing pharmacy closures and patient access problems.

Transcript Highlights:

• At this time, state funding pressures and pending Medicaid rate cuts are compounding those issues.
• At this time, state funding pressures and pending Medicaid rate cuts are compounding those issues.
• This allows us to keep discounts that pharmaceuticals... ...to help hospitals exactly like ours.
• This allows us to keep discounts that pharmaceutical companies choose to give in exchange for selling
• The Pharmaceutical Labor Management Association, also known as Philema, is opposed to 5981.

Summary: The Ways and Means Committee held a public hearing on multiple bills, beginning with a motion to suspend the five-day notice rule for a long list of Senate bills, which passed on a voice vote. The committee first heard Substitute Senate Bill 6026, a governor-request housing bill that would require cities and counties over 30,000 population to allow residential uses in commercial and mixed-use zones, limit mixed-use/ground-floor commercial requirements in some areas, and allow added height where such requirements are imposed. The lieutenant governor testified strongly in support, arguing the bill would add needed housing capacity without requiring ground-floor retail burdens. The hearing on SB 6026 was then suspended so the committee could move through the agenda. The committee then heard Senate Bill 6294, a broad local government finance measure with eight parts, including expanded uses for certain REET revenues, a new county public utility tax, a new local sales tax for children and family services, expanded housing-related tax uses, changes to county levy structure, longer lid lift periods, and expanded use of rental car tax revenue. Local government, housing, and public health witnesses largely supported the bill, emphasizing flexibility for affordable housing, rental assistance, children’s services, and county fiscal stability. Opponents, including wireless industry, water/sewer district, auto dealer, realtors, energy, and cannabis representatives, objected to specific tax provisions as regressive, costly, or likely to raise consumer prices. Several witnesses requested amendments, including adding public health clinic funding and flood recovery language from House bills. The committee also heard Substitute Senate Bill 5400 on local news sustainability, which would create a state grant program funded by a surcharge on large search engines and social media platforms to support journalism jobs and the Murrow Fellowship program. News organizations, the League of Women Voters, open government advocates, and local journalism supporters testified in favor, saying local news is essential to civic life and that the bill would help sustain reporting without using general fund dollars. Technology industry representatives opposed the bill, arguing it unfairly singles out tech companies and could face legal challenges. The committee then heard Senate Bill 6211, which would let opt-in GMA jurisdictions impose REET-2 without voter approval; cities and counties supported it as a parity and infrastructure funding measure, while Realtors opposed the loss of voter approval. Senate Bill 5650, authorizing local cannabis excise taxes, drew support from some local officials but strong opposition from cannabis businesses, which argued Washington’s cannabis taxes are already too high and drive sales to the illicit market. Senate Bill 6033, waiving penalties and interest for taxpayers who failed to collect new sales tax on certain services, was supported by NFIB as a compliance and fairness measure. Senate Bill 6297, exempting temporary staffing services for nonprofit behavioral health providers from sales tax, drew strong support from behavioral health organizations citing workforce shortages and unsustainable costs. Finally, Senate Bill 6343, extending and expanding tax relief for disaster-damaged property and repairs, was presented as aid for flood recovery; local officials testified in support. No final committee votes on the bills were taken in the portion of the meeting provided.